Article

Choice of medication should be determined case by case

Author(s):

Philadelphia-In about 80% of glaucoma cases, medication is the preferred initial approach for lowering IOP. However, the choice of medication must be made with the cognition of individual patient differences that can affect the tolerability and effectiveness of the drug, noted Marlene Moster, MD, clinical professor of ophthalmology, Thomas Jefferson Medical Col- lege, Philadelphia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.